ID   R-3327-AT-2.1
AC   CVCL_3569
AS   CVCL_L304
SY   AT-2.1; AT2.1; Dunning AT2.1
DR   CLO; CLO_0001758
DR   CLO; CLO_0008715
DR   ATCC; JHU-30
DR   ECACC; 94101450
DR   KCLB; 60050
DR   Wikidata; Q54948963
RX   PubMed=2065333;
RX   PubMed=3174494;
CC   Discontinued: ATCC; JHU-30; true.
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
CC   Breed/subspecies: Copenhagen; RS=RS:0000184.
DI   NCIt; C64013; Adenocarcinoma of the rat prostate
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_L303 ! R-3327-AT-2
SX   Male
AG   1Y10M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 13
//
RX   PubMed=2065333;
RA   Ichikawa T., Ichikawa Y., Isaacs J.T.;
RT   "Genetic factors and suppression of metastatic ability of prostatic
RT   cancer.";
RL   Cancer Res. 51:3788-3792(1991).
//
RX   PubMed=3174494; DOI=10.1002/pros.2990130208;
RA   Isaacs J.T., Hukku B.;
RT   "Nonrandom involvement of chromosome 4 in the progression of rat
RT   prostatic cancer.";
RL   Prostate 13:165-188(1988).
//